- Medical - Diagnostics & Research
- Healthcare
Thermo Fisher Scientific Inc.
TMO · US ·
NYSE
596.18
USD
-3.86
(0.65%)
-
16.29
EPS
-
36.61
P/E
-
228B
MARKET CAP
-
0.25%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 16.4 | 21.9 | 20.1 | 22.8 | 30.6 | 33.5 | 15.30% |
| Avg. Estimate | 16.2 | 21.7 | 18.6 | 21.5 | 30.2 | 33 | 15.30% |
| Low Estimate | 16 | 21.5 | 15.6 | 20.2 | 29.9 | 32.7 | 15.30% |
| No. Of Analysts | 16 | 18 | 16 | 9 | 7 | 4 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 42.4B | 43B | 46.2B | 49.6B | 53.1B | 53.8B | 4.87% |
| Avg. Estimate | 42.3B | 42.9B | 45.7B | 49.1B | 52.5B | 53.2B | 4.67% |
| Low Estimate | 42.3B | 42.8B | 45.3B | 48.7B | 52.1B | 52.8B | 4.53% |
| No. Of Analysts | 19 | 16 | 19 | 20 | 10 | 9 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 7.46B | 8.49B | 7.78B | 8.84B | 11.9B | 13B | 11.71% |
| Avg. Estimate | 6.22B | 8.44B | 6.93B | 8.04B | 11.7B | 12.8B | 15.53% |
| Low Estimate | 4.98B | 8.36B | 6.03B | 7.83B | 11.6B | 12.7B | 20.58% |
| No. Of Analysts | 19 | 16 | 19 | 20 | 10 | 9 |